Mission Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Sell |
2,234
-58
| -3% | -$7.34K | 0.01% | 567 |
|
|
2025
Q1 | $293K | Sell |
2,292
-754
| -25% | -$96.4K | 0.01% | 529 |
|
|
2024
Q4 | $403K | Buy |
3,046
+24
| +0.8% | +$3.17K | 0.01% | 463 |
|
|
2024
Q3 | $440K | Hold |
3,022
| – | – | 0.01% | 439 |
|
|
2024
Q2 | $415K | Hold |
3,022
| – | – | 0.01% | 432 |
|
|
2024
Q1 | $415K | Hold |
3,022
| – | – | 0.01% | 452 |
|
|
2023
Q4 | $410K | Buy |
3,022
+506
| +20% | +$68.7K | 0.01% | 401 |
|
|
2023
Q3 | $308K | Sell |
2,516
-230
| -8% | -$28.1K | 0.01% | 427 |
|
|
2023
Q2 | $349K | Buy |
2,746
+120
| +5% | +$15.2K | 0.01% | 407 |
|
|
2023
Q1 | $339K | Sell |
2,626
-276
| -10% | -$35.6K | 0.01% | 400 |
|
|
2022
Q4 | $381K | Buy |
2,902
+34
| +1% | +$4.46K | 0.02% | 366 |
|
|
2022
Q3 | $335K | Sell |
2,868
-148
| -5% | -$17.3K | 0.02% | 358 |
|
|
2022
Q2 | $355K | Buy |
3,016
+613
| +26% | +$72.2K | 0.02% | 356 |
|
|
2022
Q1 | $313K | Buy |
2,403
+212
| +10% | +$27.6K | 0.01% | 391 |
|
|
2021
Q4 | $334K | Buy |
2,191
+75
| +4% | +$11.4K | 0.02% | 385 |
|
|
2021
Q3 | $342K | Sell |
2,116
-500
| -19% | -$80.8K | 0.02% | 359 |
|
|
2021
Q2 | $428K | Buy |
2,616
+602
| +30% | +$98.5K | 0.02% | 307 |
|
|
2021
Q1 | $303K | Buy |
2,014
+325
| +19% | +$48.9K | 0.02% | 360 |
|
|
2020
Q4 | $256K | Buy |
1,689
+120
| +8% | +$18.2K | 0.02% | 358 |
|
|
2020
Q3 | $212K | Buy |
1,569
+70
| +5% | +$9.46K | 0.02% | 335 |
|
|
2020
Q2 | $205K | Buy |
+1,499
| New | +$205K | 0.02% | 316 |
|